Antidepressant-associated sexual dysfunction in outpatients

Area of Science:

• Psychiatry
• Pharmacology
• Sexual Medicine

Background:

• Antidepressant medications are frequently associated with sexual dysfunction.
• This adverse effect can lead to patients discontinuing necessary treatment.
• Understanding prevalence and contributing factors is crucial for patient care.

Purpose of the Study:

• To assess the prevalence of sexual dysfunction in antidepressant users.
• To identify factors associated with antidepressant-induced sexual dysfunction.
• To compare sexual dysfunction levels across different antidepressant types and genders.

Main Methods:

• A cross-sectional study involving 452 participants (291 males, 161 females).
• Data collected via demographic forms and the Psychotropic-related Sexual Dysfunction Questionnaire (PreSEXDQ).
• Statistical analysis to compare sexual dysfunction levels based on gender and antidepressant type.

Main Results:

• High prevalence of sexual dysfunction observed: 88.7% in females and 84.5% in males.
• Among females, bupropion users reported less sexual dysfunction than users of SSRIs, SNRIs, or vortioxetine.
• No significant differences in sexual dysfunction were found among males based on antidepressant type.

Conclusions:

• Gender and specific antidepressant type are important factors in managing psychotropic-related sexual dysfunction.
• Further research is needed to establish a causal link between psychiatric medication and sexual dysfunction leading to treatment discontinuation.